Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.320
-0.010 (-0.75%)
At close: Feb 27, 2026, 4:00 PM EST
1.340
+0.020 (1.52%)
After-hours: Feb 27, 2026, 7:39 PM EST
Revelation Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.01 | 4.43 | 4.51 | 5.49 | 5.04 | |
| Research & Development | 4.06 | 3.55 | 4.15 | 5.38 | 6.91 | |
| Operating Expenses | 9.07 | 7.98 | 8.66 | 10.86 | 11.95 | |
| Operating Income | -9.07 | -7.98 | -8.66 | -10.86 | -11.95 | |
| Other Non Operating Income (Expenses) | 0.16 | -7.06 | 8.54 | 0.03 | -0.04 | |
| Pretax Income | -8.91 | -15.04 | -0.12 | -10.83 | -11.99 | |
| Net Income | -8.91 | -15.04 | -0.12 | -10.83 | -11.99 | |
| Preferred Dividends & Other Adjustments | 5.95 | - | - | - | - | |
| Net Income to Common | -14.87 | -15.04 | -0.12 | -10.83 | -11.99 | |
| Shares Outstanding (Basic) | 1 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 1 | 0 | - | - | - | |
| Shares Change (YoY) | 4243.58% | - | - | - | - | |
| EPS (Basic) | -23.95 | -1052.23 | - | - | - | |
| EPS (Diluted) | -23.95 | -1052.23 | - | - | - | |
| Free Cash Flow | -8.27 | -18.34 | -7.29 | -11.22 | -11.22 | |
| Free Cash Flow Per Share | -13.32 | -1283.27 | - | - | - | |
| EBITDA | -9.04 | -7.95 | -8.63 | -10.84 | -11.93 | |
| D&A For EBITDA | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
| EBIT | -9.07 | -7.98 | -8.66 | -10.86 | -11.95 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.